Kidney Function Tied to Alzheimer's Biomarkers in Study

A groundbreaking study published in Neurology has highlighted the relationship between kidney function and Alzheimer's biomarkers in the blood. The research indicates that individuals with impaired kidney function tend to exhibit elevated levels of various Alzheimer's disease biomarkers, although this condition does not appear to increase the overall risk of developing dementia.

Introduction

The kidneys serve as vital organs that filter waste and toxins from the bloodstream, a crucial function for maintaining overall health. The recent findings by Dr. Francesca Gasparini from Karolinska Institutet in Stockholm, Sweden, suggest that poor kidney function may influence the levels of Alzheimer's biomarkers such as tau protein, amyloid beta, and neurofilament light chain in the blood. However, this study raises questions regarding the implications for cognitive health and dementia risk.

Study Design and Methodology

The study involved a cohort of 2,279 participants, with an average age of 72 years, all of whom were free from dementia at the onset of the study. The methodology included the following:

• Comprehensive medical examinations and cognitive skill assessments.
• Blood tests were conducted to evaluate kidney function alongside the presence of Alzheimer's biomarkers.
• Participants were monitored over an average period of eight years.

Population Breakdown

Participants were stratified into two distinct groups:

Key Findings and Their Implications

The study's key findings reveal important connections between kidney health and biomarkers for Alzheimer's disease:

• Individuals with poor kidney function showed significantly higher levels of most evaluated biomarkers.
• The association remained consistent even after excluding participants who developed dementia during the study period.
• Notably, enhanced risk factors emerged for those with impaired kidney function and elevated neurofilament light chain, suggesting nearly twice the risk of dementia compared to those with preserved kidney health.

Analysis of Results

Despite the positive correlation between renal impairment and biomarker levels, the study cautioned against concluding that kidney dysfunction directly causes heightened dementia risk. Instead, it proposes that while both conditions may co-occur, the causative pathways require more extensive exploration.

“When looking at these biomarkers in older adults, keeping an eye on kidney health may be more important than one might think.” – Dr. Francesca Gasparini

Study Limitations

While the findings are significant, certain limitations must be acknowledged:

• Alzheimer's-related biomarkers were measured only once, lacking longitudinal tracking that could indicate how kidney health may impact biomarker changes over time.
• The study population was predominantly educated and urban, which may limit the generalizability of the results to broader demographics.

Conclusions and Future Directions

The study advocates for a multidimensional approach to assessing Alzheimer's biomarkers, highlighting that renal function should be an integral consideration in understanding dementia risk and progression. Future research could focus on:

• Investigating how ongoing changes in kidney health could affect Alzheimer's progression and biomarker levels.
• Exploring the biological mechanisms that underpin the association between kidney function and Alzheimer's biomarkers.

Additional Information

For further details, the full study can be accessed via the following link: Poor kidney health linked to higher levels of Alzheimer's biomarkers in blood.

References

• Neurology. (2025). Poor kidney health linked to higher levels of Alzheimer's biomarkers in blood. Retrieved from https://medicalxpress.com/news/2025-12-poor-kidney-health-linked-higher.html